Enzymit

Enzymit is setting a new paradigm for bioproduction through the design and creation of novel enzymes that streamline production processes, reduce costs and promote sustainability. Through cell-free, synthetic biology bioproduction, we aim to make faster, simpler, and more cost-effective than fermentation-based methods, meeting the demands of a constantly evolving world. Established in 2020 by experts in computational science, Enzymit uses deep learning algorithms and high-throughput testing methods to develop novel enzymes for various applications such as fine chemical manufacturing, foodtech, health, biodefense and more. Our team collaborates with global manufacturers across multiple industries, driving both expansion and market impact

Bioproduction,deep learning algorithms,enzymes,bioengineering,computational protein design,cell-free production,and sustainability

Enzymit operates in the Biotechnology research industry.

Enzymit's revenue is 11m - 100m

Enzymit has 11 - 50 employees.